Aspirin for Primary Prevention of Cardiovascular Events: Meta-Analysis of Randomized Controlled Trials and Subgroup Analysis by Sex and Diabetes Status — Manling Xie (2014) | RDL Network
Aspirin for Primary Prevention of Cardiovascular Events: Meta-Analysis of Randomized Controlled Trials and Subgroup Analysis by Sex and Diabetes Status
Article 2014 en
Authors
MX
Manling Xie
ZS
Zhilei Shan
YZ
Yan Zhang
Abstract
1 min read
The use of low-dose aspirin was beneficial for primary prevention of CVD and the decision regarding an aspirin regimen should be made on an individual patient basis. The effects of aspirin therapy varied by sex and diabetes status. A clear benefit of aspirin in the primary prevention of CVD in people with diabetes needs more trials.
Kamal Awad, M Mohammed, Mahmoud Zaki, Abdelrahman Ibrahim Abushouk, Professor Gregory Lip, Michael J. Blaha, Carl J. Lavie, Peter P. Tóth, J. Wouter Jukema, Naveed Sattar, Maciej Banach
Alan P. Jacobsen, Zi Lun Lim, Blair Chang, Kaleb D. Lambeth, Thomas M. Das, Colin Gorry, Michael McCague, Faisal Sharif, Darren Mylotte, William Wijns, Patrick W. Serruys, Roger S. Blumenthal, Seth S. Martin, John W. McEvoy
Jaqui Walker, Marco Cattaneo, Lina Badimón, Giancarlo Agnelli, Andrew T. Chan, Ángel Lanas, Bianca Rocca, Peter M. Rothwell, Paola Patrignani, Ruth E. Langley, Gemma Vilahur, Francesco Cosentino
Nicola Veronese, Jacopo Demurtas, Trevor Thompson, Marco Solmi, Gabriella Pesolillo, Stefano Celotto, Tommaso Barnini, Brendon Stubbs, Stefania Maggi, Alberto Pilotto, Graziano Onder, Evropi Τheodoratou, Alberto Vaona, Joseph Firth, Lee Smith, Ai Koyanagi, John P A Ioannidis, Ioanna Tzoulaki
Discussion(0)
No comments yet. Be the first to comment.